Medically reviewed by Dr. Mario Menendez, MD | Medical Director
Urinary tract infections (UTIs) are often treated as an uncomfortable but routine health problem. You take an antibiotic, drink plenty of water, and move on. For some women, though, especially during and after menopause, a UTI can become much more than an inconvenience.
A September 2026 USA Today article shared the story of 78-year-old Roselin Shankland, whose UTI spread into her bloodstream and led to organ failure and fatal sepsis. Her story is heartbreaking, and it raises an important question for women, families, and providers: are we paying enough attention to the link between menopause and recurrent UTIs? Many women know estrogen can treat hot flashes or vaginal dryness, but far fewer know that vaginal estrogen for UTIs can help prevent repeat infections in the right patients.
Why UTIs Can Become More Common After Menopause
When people talk about menopause, hot flashes, night sweats, mood changes, and poor sleep tend to get most of the attention. But falling estrogen affects much more than body temperature, and some of its biggest effects happen in the vaginal and urinary tissues.
How Falling Estrogen Changes Your Body
Estrogen receptors are found throughout the vagina, vulva, urethra, and lower urinary tract. As estrogen levels drop during menopause, these tissues can become thinner, drier, less stretchy, and easier to irritate. The vaginal environment changes too. Estrogen helps support healthy bacteria called Lactobacillus, which keep the vagina naturally acidic. When estrogen declines, these helpful bacteria can decrease and vaginal pH can rise, making it easier for bacteria linked to UTIs to settle in.
What Is Genitourinary Syndrome of Menopause (GSM)?
Together, these changes can lead to a condition called genitourinary syndrome of menopause, or GSM. Here are some of the most common symptoms of GSM:
- Vaginal dryness, burning, or irritation
- Pain during intercourse
- Less natural lubrication
- A frequent or urgent need to urinate
- Burning when you urinate
- UTIs that keep coming back
Unlike some menopause symptoms that may fade over time, GSM is usually a long-term condition that can get worse without treatment. Our article on symptoms of low estrogen includes a short video from one of our providers explaining what causes GSM.
When a UTI Becomes More Than a UTI
For most women, a UTI stays in the bladder and clears up with treatment. In some cases, however, the infection can spread, turning a common problem into a serious one.
How a UTI Can Lead to Sepsis
Urinary infections can sometimes travel up to the kidneys or enter the bloodstream. When the body’s response to an infection becomes severe and life-threatening, it is called sepsis. Sepsis can lead to hospitalization and, in the worst cases, death. This risk is one reason recurrent UTIs should not be brushed off as a normal part of getting older.
Asking a Bigger Question
Ms. Shankland’s story brought attention to a larger question: could some recurrent UTIs in menopausal women be prevented by treating the hormone changes behind them? Research suggests that for the right patients, vaginal estrogen can play an important role.
Where Vaginal Estrogen Comes In
Vaginal estrogen works differently than the hormone therapy many women picture when they think of menopause treatment. It targets the tissues where GSM starts, which is why it has drawn so much attention for UTI prevention.
What Is Vaginal Estrogen?
Vaginal estrogen is a form of estrogen applied directly to the vagina and nearby tissues. It comes in a few forms, including vaginal creams, vaginal tablets or inserts, and vaginal rings. Because the estrogen is delivered right where it is needed, it can help correct some of the tissue and bacterial changes that come with menopause.
How Vaginal Estrogen Helps
The goal is not simply to add moisture. Estrogen can help vaginal tissue become healthier and thicker, lower vaginal pH, and restore beneficial Lactobacillus bacteria. These changes may also reduce the risk of recurrent urinary tract infections. In fact, the 2025 American Urological Association guideline on GSM states that clinicians should recommend local low-dose vaginal estrogen for patients with GSM and recurrent UTIs to reduce the risk of future infections.
What Does the Research Say About Vaginal Estrogen for UTIs?
The link between vaginal estrogen and recurrent UTIs has been studied for decades. Below are the key studies, starting with the trial that first put this connection on the map.
A Landmark Randomized Trial
One of the most cited studies was published in The New England Journal of Medicine in 1993. Researchers followed postmenopausal women with recurrent UTIs and compared vaginal estriol, a type of estrogen, with a placebo. The difference was large. Women using intravaginal estriol had about 0.5 UTIs per year, compared with 5.9 UTIs per year in the placebo group. Researchers also saw Lactobacillus return in many women using estrogen, along with lower vaginal pH and fewer of the bacteria linked to UTIs.
More Recent Randomized Research
A more recent randomized clinical trial compared vaginal estrogen, given by ring or cream, with a placebo in postmenopausal women with recurrent UTIs. After six months, fewer women using vaginal estrogen had a UTI than women using the placebo. This added more evidence that modern vaginal estrogen products can help prevent repeat infections.
What the Larger Body of Evidence Shows
A meta-analysis, which combines results from many studies, reviewed randomized trials with more than 4,700 patients. Across the trials that tested vaginal estrogen, women were about 58% less likely to have recurrent UTIs than women given a placebo. The same analysis found no clear benefit from oral estrogen pills, which shows why local vaginal treatment and whole-body hormone therapy should not be treated as the same thing.
New Research on Vaginal Estrogen, Sepsis, and Hospitalization
Newer research has taken the question one step further. Instead of only counting infections, researchers have started looking at whether vaginal estrogen is linked to fewer serious outcomes.
What the 2026 Epic Cosmos Study Found
A large 2026 observational study published in the journal Urology used Epic Cosmos health record data from about 1.9 million women with recurrent UTIs. Researchers compared women who received a vaginal estrogen prescription with women who did not. Women who received vaginal estrogen had lower odds of sepsis, hospitalization, and death from any cause, and these links showed up across the age groups studied.
How to Read These Results
This is an important finding, but it needs to be read carefully. Because this was an observational study and not a randomized trial, it cannot prove that vaginal estrogen directly prevented sepsis, hospitalization, or death. Women who received vaginal estrogen may have differed in other ways that affected their health. Still, when combined with the randomized trials showing fewer UTIs, the findings suggest that preventing recurrent UTIs may be about much more than avoiding discomfort.
“I see a lot of women who have been told to just keep taking antibiotics every time a UTI comes back. The AUA guideline on GSM now recommends low-dose vaginal estrogen for women with GSM and recurrent UTIs, and the research behind it goes back more than 30 years. For the right patient, it is a simple, local treatment that can help break the cycle, and that conversation should happen sooner rather than later.”
Dr. Mario Menendez, MD, Medical Director
Is Vaginal Estrogen the Same as Traditional HRT?
This is one of the most common sources of confusion about vaginal estrogen. The short answer is no, and understanding the difference can help women who have avoided asking about treatment because of worries about hormones.
Local Treatment vs. Whole-Body Treatment
Systemic hormone therapy sends hormones throughout the body and may be prescribed for symptoms like hot flashes, night sweats, and poor sleep. You can learn more about that approach in our guide to BHRT and women’s health. Low-dose vaginal estrogen, on the other hand, is designed to work mainly on the vaginal and urinary tissues. The American Urological Association notes that overwhelming evidence shows minimal systemic absorption with low-dose vaginal estrogen, meaning very little reaches the rest of the body.
Why Your Medical History Still Matters
Even though vaginal estrogen acts locally, it is still a prescription treatment. Women with a history of certain hormone-sensitive cancers or other medical conditions should talk through the risks, benefits, and alternatives with their healthcare provider. (Always speak with a qualified provider before starting any hormone treatment. Our providers at Aqua Vitae can help you weigh your options.)
Why Are We Talking About This Now?
Vaginal estrogen is not a new therapy. What is changing is how much attention doctors, researchers, and public health leaders are paying to the link between menopause, GSM, and recurrent infections.
A National Push for Awareness
In March 2026, the U.S. Department of Health and Human Services announced a collaboration with the American Urological Association to raise awareness of local estrogen therapy for postmenopausal women with GSM and recurrent UTIs. That effort comes alongside updated clinical guidelines and new research examining more serious outcomes, such as sepsis.
Menopause Care Is Expanding
The conversation around menopause is growing beyond hot flashes. Good menopause care can include sexual health, bone health, heart health, metabolic health, memory and focus, and vaginal and urinary health. For a broader look at how menopause can affect your body, our guide to managing menopause symptoms is a helpful place to start.
Recurrent UTIs Are Not Something You Have to Accept
Many women quietly put up with symptoms they assume are just part of getting older. These symptoms are common, but that does not mean they are normal or untreatable.
Symptoms That May Be Connected
Maybe you keep getting UTIs, sex suddenly hurts, you feel dry or irritated all the time, or you always feel like you have to urinate. Maybe it all started after menopause. These symptoms may not be separate problems. They may all signal the same underlying condition, GSM, and evidence-based treatments are available.
When to Talk to a Healthcare Provider
Consider talking to a provider if you have recurrent UTIs or ongoing symptoms like vaginal dryness, burning, painful sex, urinary urgency, or frequent urination. It is also important not to assume every urinary symptom is caused by menopause, since infections and other conditions can cause similar symptoms. Seek prompt medical care if a suspected UTI comes with fever, chills, vomiting, severe back or side pain, confusion, rapid breathing, or feeling very sick, because these can signal a more serious infection.
What to Expect at Aqua Vitae
At Aqua Vitae, getting answers about recurrent UTIs and other menopause symptoms usually follows these steps:
- Schedule a consultation to talk through your symptoms, UTI history, and health goals.
- Complete comprehensive lab work to get a clear picture of your hormones and overall health.
- Review your results with your provider to understand what may be driving your symptoms.
- Discuss treatment options that fit your health history, including local treatments for vaginal and urinary health.
- Return for follow-up visits so your provider can adjust your plan as your body responds.
Frequently Asked Questions About Vaginal Estrogen and UTIs
Women often have questions about how vaginal estrogen works and whether it is right for them. Here are clear answers to the ones we hear most often.
Can vaginal estrogen prevent UTIs?
Research shows that vaginal estrogen can reduce recurrent UTIs in many postmenopausal women. Current urology guidelines recommend local low-dose vaginal estrogen for patients with GSM and recurrent UTIs to lower the risk of future infections.
Why does menopause cause more UTIs?
Falling estrogen can change vaginal and urinary tissues, raise vaginal pH, and reduce helpful Lactobacillus bacteria. These changes may make it easier for UTI-linked bacteria to settle in.
Is vaginal estrogen the same as hormone replacement therapy?
Not exactly. Vaginal estrogen is usually a local, low-dose treatment that works mainly on vaginal and urinary tissues. Systemic hormone therapy sends hormones throughout the body and may be used for broader menopause symptoms.
Is vaginal estrogen safe?
Low-dose vaginal estrogen usually results in very little estrogen reaching the rest of the body and is an established treatment for GSM. Individual risks vary, so talk with your provider about your personal and family medical history.
Can vaginal estrogen treat an active UTI?
No. Vaginal estrogen is mainly used to improve tissue health and help prevent repeat UTIs. It is not a replacement for testing and treating an active infection.
What are other symptoms of GSM?
GSM can cause vaginal dryness, burning, itching, painful sex, less lubrication, urinary urgency, frequent urination, painful urination, and recurrent UTIs.
The Takeaway on Vaginal Estrogen for UTIs
For decades, women’s menopause symptoms were often brushed aside as something to simply endure. Today, we are learning much more about how falling hormones affect the whole body, including vaginal and urinary health. Vaginal estrogen is not right for every woman, and it does not guarantee you will never get another UTI. But for peri- and postmenopausal women with GSM and recurrent UTIs, it is an evidence-based treatment worth discussing with a knowledgeable provider.
You do not have to accept feeling uncomfortable just because your hormones are changing. Schedule a consultation with Aqua Vitae, and our providers will look beyond individual symptoms, review your health history, and build a personalized plan around your goals.
Sources and Further Reading
- USA Today: Menopause, UTIs, Vaginal Estrogen and Sepsis. The September 2026 article that brought new attention to the serious risks of recurrent UTIs after menopause and the role vaginal estrogen may play in prevention.
- American Urological Association: Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025). Current clinical guidance recommends local low-dose vaginal estrogen for patients with GSM and recurrent UTIs to reduce their risk of future infections.
- Raz R, Stamm WE: A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract Infections. New England Journal of Medicine, 1993. This landmark randomized, placebo-controlled trial found a large drop in recurrent UTIs among women using intravaginal estriol.
- Ferrante KL, et al.: Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial. A more recent randomized trial testing vaginal estrogen by ring or cream to prevent recurrent UTIs in postmenopausal women.
- Chen YY, et al.: Estrogen for the Prevention of Recurrent Urinary Tract Infections in Postmenopausal Women: A Meta-Analysis of Randomized Controlled Trials. International Urogynecology Journal, 2021. This analysis found that vaginal estrogen was linked to significantly fewer recurrent UTIs compared with placebo, while oral estrogen showed no clear benefit.
- Vaginal Estrogen Prescription Is Associated With Reduced Risk of Serious Adverse Outcomes in Women of All Age Groups With Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis. Urology, 2026. This large observational study of nearly 1.9 million women with recurrent UTIs found that vaginal estrogen prescriptions were linked to lower odds of sepsis, hospitalization, and death from any cause. Because the study was observational, it shows a link, not proof that vaginal estrogen caused these lower rates.
- U.S. Department of Health and Human Services: HHS and American Urological Association Announce Landmark Collaboration to Advance Women’s Health. March 2026. This initiative aims to raise awareness of evidence-based local estrogen therapy for postmenopausal genitourinary health and recurrent UTIs.
- American Urological Association: Comments on Menopause Hormone Therapy, Docket No. FDA-2025-N-2589. September 2025. The AUA’s letter to the FDA summarizing evidence on the safety of low-dose vaginal estrogen, including minimal systemic absorption.
This article is for educational purposes and is not intended to diagnose, treat, cure, or prevent any disease. Individual treatment recommendations should be made in consultation with a qualified healthcare provider.
